Shionogi & Co (TYO:4507) disclosed the dissolution of its joint ventures with Ping An Insurance Group (HKG:2318, SHA:601318) via the acquisition of the Chinese insurer's stakes in the JVs, according to a Monday filing with the Tokyo Stock Exchange.
The board approved Shionogi's acquisition of Ping An's 49% stake in Ping An Shionogi and Ping An Shionogi (Hong Kong), making them wholly-owned subsidiaries.
The move follows a review of the companies' strategies and aligns with Shionogi's focus on drug development in China and Asia. The joint ventures have contributed to key product approvals and AI-driven drug discovery efforts.
The share transfers are planned for January 2025 for Ping An Shionogi Hong Kong and for March 2025 for Ping An Shionogi.
Price (HKD): $2194.00, Change: $-1.5, Percent Change: -0.07%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.